Significant Ownership of Ikarian Capital, LLC

Signature - Title
/s/ Neil Shahrestani - Neil Shahrestani, Sole Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ikarian Capital, LLC.

Notify me when Ikarian Capital, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ikarian Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GLTO Galecto, Inc. Common Stock, $0.00001 par value per share 22% 285,710 Ikarian Capital, LLC 30 Nov 2025
TENX Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share 16% $6,473,244 967,600 0% Ikarian Capital, LLC 30 Nov 2025
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share 13% $3,052,472 211,538 0% Ikarian Capital, LLC 31 Jan 2026
SPRB Spruce Biosciences Inc. Common Stock, par value $0.0001 per share 11% $1,060,227 121,356 0% Ikarian Capital, LLC 31 Oct 2025
NXTC NextCure, Inc. Common Stock, $0.001 par value per share 10% $4,715,825 363,035 Ikarian Capital, LLC 31 Dec 2025
TRAW Traws Pharma, Inc. Common stock, par value $.01 per share 10% $1,308,164 +$359,065 812,524 +38% Ikarian Capital, LLC 31 Dec 2025
GRTX Galera Therapeutics, Inc. Common Stock, $0.001 par value per share 10% $376,934 7,538,690 Ikarian Capital, LLC 31 Dec 2024
CNTB Connect Biopharma Holdings Limited Ordinary Shares, par value $0.000174 per Share 8.8% $13,910,809 4,933,086 Ikarian Capital, LLC 31 Dec 2025
PTHS Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share 8.4% $6,534,617 +$1,771,892 255,758 +37% Ikarian Capital, LLC 31 Dec 2025
CHRO Channel Therapeutics Corp Common Stock, par value $0.0001 per share 7.3% $564,287 440,849 Ikarian Capital, LLC 31 Dec 2024
KZIA Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares 5.1% $3,740,056 580,754 Ikarian Capital, LLC 31 Dec 2025
FBRX Forte Biosciences, Inc. Common Stock, $0.001 par value 5% $6,516,387 +$89,063 617,667 +1.4% Ikarian Capital, LLC 30 Jun 2025
IBIO IBIO, Inc. Common Stock 5% $947,430 1,151,051 Ikarian Capital, LLC 30 Sep 2025
ACOG Alpha Cognition Inc. Common Shares, no par value 4.9% $6,865,684 +$574,548 1,056,259 +9.1% Ikarian Capital, LLC 31 Dec 2025
CPIX Cumberland Pharmaceuticals Inc. Common Stock, no par value 4.9% $3,545,020 730,932 Ikarian Capital, LLC 31 Mar 2025
RLMD Relmada Therapeutics, Inc. Common Stock, par value $0.001 par value per share 4.8% $7,122,152 3,543,359 Ikarian Capital, LLC 30 Sep 2025
GCTK Glucotrack, Inc. Common Stock, par value $0.001 per share 4.5% $175,071 45,830 Ikarian Capital, LLC 31 Dec 2025
ATXI Avenue Therapeutics, Inc. Common Stock 4.1% $86,341 -$6,059 130,820 -6.6% Ikarian Capital, LLC 31 Dec 2025
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value 3.8% $9,049,101 -$6,100,673 711,967 -40% Ikarian Capital, LLC 30 Sep 2025
AEMD Aethlon Medical, Inc. Common Stock, $0.001 par value per share 2% $5,685 -$449,150 15,366 -99% Ikarian Capital, LLC 30 Sep 2025

Schedules 13D/G Reported by Ikarian Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.